Body Composition

CJC + Ipamorelin

CJC-1295 + Ipamorelin Blend

The classic synergistic growth-hormone secretagogue pairing

Research Status: Research compound; widely studied components CJC + IPA Blend CJC-1295/Ipamorelin
Mechanism of Action

How it works

This blend pairs CJC-1295 (a GHRH analog that raises the amplitude of GH pulses) with Ipamorelin (a selective ghrelin-receptor agonist that initiates a GH pulse). Acting on two different receptors, they are studied for a synergistic, cleaner GH release.

Areas of Research

What the research explores

In published research, CJC + Ipamorelin has been studied in connection with the following. These describe findings reported in the literature — not approved uses, claims, or outcomes to expect.

  • Two complementary GH-release mechanisms
  • Studied for body composition and recovery
  • Ipamorelin's selectivity limits off-target effects
  • Preserves pulsatile GH release
  • Popular research pairing
Research Highlight

CJC-1295 and Ipamorelin act on separate receptors (GHRH vs. ghrelin), which is the basis for the synergy researchers study when the two are combined.

Safety Profile

Adverse events & gaps

Components are well-characterized; Ipamorelin is noted for selectivity. Injection-site reactions most commonly reported.



Stay Informed on
Peptide Research

Research summaries, newly documented peptides, and clinical trial updates delivered to your inbox.

No spam. Unsubscribe at any time.